Studies show increased oxidative damage in the brains of subjects with Alzheimer's disease (AD) and mild cognitive impairment (MCI). To determine if RNA oxidation occurs in MCI, sections of hippocampus/ parahippocampal gyrus (HPG) from 5 MCI, 5 late stage AD (LAD) and 5 age-matched normal control (NC) subjects were subjected to immunohistochemistry using antibodies against 8-hydroxyguanine (8-OHG) and 1-N2-propanodeoxyguanosine (NPrG). Confocal microscopy showed 8-OHG and NPrG immunostaining was significantly (p b 0.05) elevated in MCI and LAD HPG compared with NC subjects and was predominately associated with neurons identified using the MC-1 antibody that recognizes conformational alterations of tau, which are associated with early neurofibrillary tangle formation. Pretreating sections with RNase or DNase-I showed immunostaining for both adducts was primarily associated with RNA. In addition, levels of both adducts in MCI were comparable to those measured in LAD, suggesting RNA oxidation may be an early event in the pathogenesis of neuron degeneration in AD.
Introduction
An increasing body of evidence supports a role for oxidative stress in the pathogenesis of Alzheimer's disease (AD). Multiple studies over the past 10 to 15 years show increased lipid peroxidation, and protein, DNA, and RNA oxidation are present in multiple vulnerable regions of the late stage AD (LAD) brain (Markesbery and Lovell, 1998; Picklo et al., 2002; Nunomura et al., 2006; Sultana et al., 2006) . Although these studies show oxidative damage is present in LAD, it is unclear whether oxidative damage is a consequence of the disease or whether it occurs early in the pathogenesis, thus making it a potential therapeutic target.
With recent emphasis on early diagnosis of adult dementing disorders, mild cognitive impairment (MCI), a transition between normal aging and dementia, has become a research focus. Subjects with MCI convert to AD or other dementias at a rate of 10% to 15% per year (Knopman et al., 2003) , although approximately 5% remain stable or correct back to normal (Bennett et al., 2002; DeCarli, 2003) . These studies also show levels of oxidative damage in MCI that are comparable to those observed in LAD, suggesting oxidative damage to a variety of cellular targets occurs early in the progression of AD and may contribute to the pathogenesis of neuron degeneration.
Although previous studies show increased levels of RNA oxidation in LAD (Nunomura et al., 1999 (Nunomura et al., , 2001 Ding et al., 2005 Ding et al., , 2006 Shan and Lin, 2006) and familial AD (Nunomura et al., 2004) as well as other neurologic disorders including Parkinson's disease (Zhang et al., 1999) and dementia with Lewy bodies (DLB) (Nunomura et al., 2002) , there have been few studies of RNA oxidation in MCI. Because RNA oxidation may lead to alterations in protein synthesis, its presence early in the progression of AD could contribute to changes in protein translation observed in AD. To determine whether RNA oxidative modification occurs in vulnerable neurons in MCI, we used immunohistochemistry and confocal microscopy to analyze sections of hippocampus/parahippocampal gyrus (HPG) double labeled for MC-1, an antibody that recognizes specific conformational changes in tau observed only in AD (Weaver et al., 2000) and antibodies against 8-hydroxyguanine (8-OHG), a byproduct of hydroxyl attack of C-8 of guanine or 1-N2-propanoguanosine (NPrG), an adduct formed between guanine and acrolein, an α,β-unsaturated aldehydic by-product of lipid peroxidation elevated in MCI and LAD brain (Lovell et al., 2001; Williams et al., 2006) .
Materials and methods

Subject selection and neuropathologic examination
Sections (10 μm) of paraffin embedded HPG were obtained from short postmortem interval (PMI) autopsies of 5 subjects with
